# Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain

> **NCT01912612** · PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 82 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT01912612
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-30
- **Primary completion:** 2019-06-28
- **Final completion:** 2019-06-28
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2020-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01912612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01912612, "Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01912612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*